ATE386547T1 - Auf in vivo abbaubaren und quellbaren modifizierten dextranhydrogelen basierende systeme zur stossweisen freisetzung biologisch aktiver stoffe - Google Patents

Auf in vivo abbaubaren und quellbaren modifizierten dextranhydrogelen basierende systeme zur stossweisen freisetzung biologisch aktiver stoffe

Info

Publication number
ATE386547T1
ATE386547T1 AT02790247T AT02790247T ATE386547T1 AT E386547 T1 ATE386547 T1 AT E386547T1 AT 02790247 T AT02790247 T AT 02790247T AT 02790247 T AT02790247 T AT 02790247T AT E386547 T1 ATE386547 T1 AT E386547T1
Authority
AT
Austria
Prior art keywords
biologically active
hydrogels
active substances
systems based
shutter release
Prior art date
Application number
AT02790247T
Other languages
English (en)
Inventor
Jo Demeester
Smedt Stefaan De
Barbara Stubbe
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of ATE386547T1 publication Critical patent/ATE386547T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AT02790247T 2001-12-21 2002-12-20 Auf in vivo abbaubaren und quellbaren modifizierten dextranhydrogelen basierende systeme zur stossweisen freisetzung biologisch aktiver stoffe ATE386547T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130518.4A GB0130518D0 (en) 2001-12-21 2001-12-21 Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels

Publications (1)

Publication Number Publication Date
ATE386547T1 true ATE386547T1 (de) 2008-03-15

Family

ID=9928061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02790247T ATE386547T1 (de) 2001-12-21 2002-12-20 Auf in vivo abbaubaren und quellbaren modifizierten dextranhydrogelen basierende systeme zur stossweisen freisetzung biologisch aktiver stoffe

Country Status (7)

Country Link
US (1) US20040258753A1 (de)
EP (1) EP1455832B1 (de)
AT (1) ATE386547T1 (de)
AU (1) AU2002366695A1 (de)
DE (1) DE60225178T2 (de)
GB (1) GB0130518D0 (de)
WO (1) WO2003053470A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041395A1 (de) 2000-08-23 2002-03-07 Stockhausen Chem Fab Gmbh Polymerdispersionen zur Feuerverhütung und -bekämpfung mit verbesserter Umweltverträglichkeit
DE10118020A1 (de) 2001-04-10 2002-10-17 Stockhausen Chem Fab Gmbh Löschwasser-Additive
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US7553669B2 (en) * 2003-12-18 2009-06-30 Palo Alto Resaerch Center Incorporated Osmotic reaction detector for monitoring biological and non-biological reactions
US7615375B2 (en) * 2003-12-18 2009-11-10 Xerox Corporation Osmotic reaction cell for monitoring biological and non-biological reactions
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
EP1595534A1 (de) * 2004-05-13 2005-11-16 Universiteit Utrecht Holding B.V. Gelzusammensetzung enthaltend geladenepolymere
US7790111B2 (en) * 2004-12-20 2010-09-07 Palo Alto Research Center Incorporated Osmotic reaction detector for detecting biological and non-biological reactions
EP1733718A1 (de) * 2005-06-14 2006-12-20 Universiteit Gent Abgabesysteme von biologisch aktiven Stoffen basiert auf beschichteten biokompatiblen abbaubaren Hydrogelen
US20080267876A1 (en) * 2005-09-20 2008-10-30 Yissum Research Development Company Nanoparticles for Targeted Delivery of Active Agent
EP2025334A1 (de) * 2007-07-25 2009-02-18 OctoPlus Sciences B.V. Wirkstofffreisetzungssystem mit verzögerter Freisetzung für wiederholte Verabreichung
US8119742B2 (en) * 2008-09-28 2012-02-21 Knc Ner Acquisition Sub, Inc. Multi-armed catechol compound blends
EP2395843B1 (de) 2009-02-13 2017-08-09 Monsanto Technology LLC Einkapseln von herbiziden zur verhinderung von ernteschäden
US8314211B2 (en) * 2009-04-07 2012-11-20 George Falus Tissue sealant for use in non compressible hemorrhage
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
UA112411C2 (uk) 2010-03-26 2016-09-12 Філіп Морріс Продактс С.А. Пригнічення подразнення рецепторів при споживанні бездимних тютюнових виробів
US9913469B2 (en) * 2010-08-18 2018-03-13 Monsanto Technology Llc Early applications of encapsulated acetamides for reduced injury in crops
WO2012121862A2 (en) * 2011-02-17 2012-09-13 University Of Florida Research Foundation Valproic acid derivative compounds
EP2841056A4 (de) 2012-04-23 2015-09-16 Massachusetts Inst Technology Stabile schichtweise beschichtete teilchen
CA2876623C (en) * 2012-06-19 2019-09-24 Obschestvo S Ogranichennoj Otvetsvennostyu "Npo Biomikrogeli" Polysaccharide microgels for cleaning water from oil, oil products and metal ions and methods for the application of these materials (versions)
WO2014059269A2 (en) * 2012-10-12 2014-04-17 Massachusetts Institute Of Technology Multilayer compositions, coated devices and use thereof
NL2010040C2 (en) * 2012-12-21 2014-06-24 Internat Inst For Diagnostic And Analitical Affairs B V Cleavable coating material having microbial functionality.
US20160106676A1 (en) * 2014-10-17 2016-04-21 Mcmaster University Method for the preparation of degradable microgel particles, and microgel compositions thereof
US10624860B2 (en) 2017-03-21 2020-04-21 International Business Machines Corporation Method to generate microcapsules with hexahydrotriazine (HT)-containing shells
MX2019015014A (es) 2017-06-13 2020-02-26 Monsanto Technology Llc Herbicidas microencapsulados.
WO2019089567A1 (en) 2017-10-30 2019-05-09 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
UA129154C2 (uk) 2019-01-30 2025-01-29 Монсанто Текнолоджі Ллс Мікрокапсульовані ацетамідні гербіциди
CN110251478B (zh) * 2019-05-15 2021-06-18 浙江维康药业股份有限公司 一种用于微滴丸的耐高温肠溶包衣工艺
WO2021002984A1 (en) 2019-05-30 2021-01-07 Massachusetts Institute Of Technology Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids
CN113398283B (zh) * 2021-06-18 2022-12-27 上海市伤骨科研究所 一种基于生物膜耦合的可吸入雾化微球及制备方法与应用
CN115236315B (zh) * 2022-07-26 2025-05-27 重庆交通大学 基于透析袋法分析生物降解塑料及微塑料动态变化的方法
WO2024035784A1 (en) * 2022-08-10 2024-02-15 Auburn University Shrinking nanomaterial for biomedical applications
CN115671369B (zh) * 2022-11-09 2023-10-27 华东理工大学 一种按需可拆的水凝胶组织粘合剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
EP0280155B1 (de) * 1987-02-25 1992-05-20 Hoechst Aktiengesellschaft Mikroenkapsulierung von biologisch aktivem Material
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
WO1997004747A1 (en) * 1995-07-27 1997-02-13 Dunn James M Drug delivery systems for macromolecular drugs
EP1240230B1 (de) * 1999-11-12 2006-03-01 MacroMed, Inc. An- und abschwellende polymermischungen

Also Published As

Publication number Publication date
WO2003053470A3 (en) 2004-03-18
EP1455832A2 (de) 2004-09-15
WO2003053470A2 (en) 2003-07-03
DE60225178T2 (de) 2009-02-12
DE60225178D1 (de) 2008-04-03
AU2002366695A1 (en) 2003-07-09
US20040258753A1 (en) 2004-12-23
GB0130518D0 (en) 2002-02-06
EP1455832B1 (de) 2008-02-20

Similar Documents

Publication Publication Date Title
ATE386547T1 (de) Auf in vivo abbaubaren und quellbaren modifizierten dextranhydrogelen basierende systeme zur stossweisen freisetzung biologisch aktiver stoffe
WO2008057867A3 (en) Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
WO2007089592A3 (en) Implantable medical device coated with bioactive agent
WO2005120462A3 (en) Biodegradable and biocompatible crosslinked polymer hydrogel prepared from pva and/or peg macromer mixtures
CY1108685T1 (el) Συστημα απελευθερωσης φαρμακου που πηζει in-situ
ATE323470T1 (de) Mikrochip-arzneistoffverabreichungssysteme und herstellungsverfahren
DE60316579D1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
MXPA06001300A (es) Articulo absorbente que comprende un material recubierto dilatable en agua.
EA201170297A1 (ru) Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
ATE310450T1 (de) Auslösbares wirkstoffabgabesystem
DK0991702T3 (da) Hydrofilt overtræk
WO2008060575A3 (en) Drug delivery system and method
WO2006052285A3 (en) Polymeric nanoparticles and nanogels for extraction and release of compounds
ATE506912T1 (de) Elektroaktive polymer-betätigte hülle für ein implantierbares oder einführbares medizinprodukt
DK1126822T3 (da) Flydende tilförselspræparater med reguleret frigivelse og lav initiel lægemiddelafgivelse
ES8707666A1 (es) Procedimiento de obtencion de una composicion de injerto para la liberacion controlada de macromoleculas
EP1803473A3 (de) Medikament enthaltender Klebstoff
PT910412E (pt) Hidrogeis hidrolisaveis para libertacao controlada
WO2007126411A3 (en) Biocompatible polymers and methods of use
WO2007148230A3 (en) Grafted polymers and uses thereof
WO2007047781A3 (en) Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
CA2340417A1 (en) Methods for forming regional tissue adherent barriers and drug delivery systems
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
AR051676A1 (es) Composiciones oftalmicas que comprenden polimeros sustituidos con polieter
CL2011003220A1 (es) Sistema de administracion de droga intraocular inyectable, biocompatible que comprende una pluralidad de microesferas y un vehiculo acuoso, en donde las microesferas consisten de un agonista alfa 2 adrenergico y de polimeros biodegradables de acido polilactico (pla); y su uso para dismunuir la presion intraocular. (div. sol. 3464-07)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties